Chemistry:Baxdrostat

From HandWiki
Revision as of 04:48, 6 February 2024 by MedAI (talk | contribs) (url)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Chemical compound
Baxdrostat
Baxdrostat.svg
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC22H25N3O2
Molar mass363.461 g·mol−1
3D model (JSmol)

Baxdrostat is an investigational drug that is being evaluated for the treatment of hypertension.[1] It is an aldosterone synthase inhibitor.[2][3]

Refences

  1. "Baxdrostat - CinCor Pharma". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800054826. 
  2. "Baxdrostat: A Novel Aldosterone Synthase Inhibitor for Treatment Resistant Hypertension". Current Problems in Cardiology 48 (11): 101918. July 2023. doi:10.1016/j.cpcardiol.2023.101918. PMID 37399857. 
  3. "Evaluating phase II results of Baxdrostat, an aldosterone synthase inhibitor for hypertension". Expert Opinion on Investigational Drugs: 1–11. October 2023. doi:10.1080/13543784.2023.2276755. PMID 37883217.